Bartelmez S H, Dodge W H, Bass D A
Immunology. 1982 Apr;45(4):605-11.
When non-adherent, Trichinella spiralis-sensitized mouse spleen cells were challenged in vitro with T. spiralis antigens, an eosinophil growth factor (Eo-GSF) was released into the culture medium. This factor was assayed by its ability to initiate eosinophil production in liquid cultures of syngeneic, non-adherent marrow cells obtained from unsensitized mice. Extracts of each parasite stage as well as excretory-secretory (ES) products of adult and muscle larva stages were compared for their ability to stimulate spleen cells to release Eo-GSF. All stages and ES products had this ability but most of the preparations had unique dose-optima and there was a very wide range with regard to the optimum dose (in microgram protein/ml): (i) preadult stage, 1 x 10(-5); (ii) muscle stage ES products, 1 x 10(-3); (iii) muscle stage, 1 x 10(-2); (iv) adult stage, 1 x 10(-2); (v) adult ES products, 1 x 10(-1); and (vi) newborn stage, 1.0. When the Eo-GSF-containing conditioned media derived from spleen cell cultures exposed to the optimum dosages were tested on the same population of marrow cells, three potency groups were identified. The rank order of potency was: muscle stage ES products greater than preadult, newborn and adult stages greater than muscles stage and adult ES products. Preliminary experiments revealed that this ranking was not maintained with regard to the release of neutrophil and macrophage growth factors by these preparations.
当非黏附性的旋毛虫致敏小鼠脾细胞在体外与旋毛虫抗原接触时,一种嗜酸性粒细胞生长因子(Eo - GSF)被释放到培养基中。通过其在从未致敏小鼠获得的同基因非黏附性骨髓细胞的液体培养物中启动嗜酸性粒细胞生成的能力来检测该因子。比较了每个寄生虫阶段的提取物以及成虫和肌幼虫阶段的排泄 - 分泌(ES)产物刺激脾细胞释放Eo - GSF的能力。所有阶段和ES产物都有此能力,但大多数制剂有独特的最佳剂量,并且在最佳剂量方面(以微克蛋白/毫升计)有非常宽的范围:(i)未成囊前期,1×10⁻⁵;(ii)肌幼虫阶段ES产物,1×10⁻³;(iii)肌幼虫阶段,1×10⁻²;(iv)成虫阶段,1×10⁻²;(v)成虫ES产物,1×10⁻¹;(vi)新生幼虫阶段,1.0。当将暴露于最佳剂量的脾细胞培养物中含Eo - GSF的条件培养基用于相同群体的骨髓细胞进行测试时,确定了三个效价组。效价的排序为:肌幼虫阶段ES产物>未成囊前期、新生幼虫和成虫阶段>肌幼虫阶段和成虫ES产物。初步实验表明,就这些制剂释放中性粒细胞和巨噬细胞生长因子而言,这种排序并不成立。